{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:33:18Z","timestamp":1787956398482,"version":"build-2784847793"},"reference-count":49,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"unspecified","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020098","name":"Innovative Health Initiative","doi-asserted-by":"publisher","award":["101132946"],"award-info":[{"award-number":["101132946"]}],"id":[{"id":"10.13039\/100020098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,5,12]]},"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) may be as high as 38% in the adult population with potential serious complications, multiple comorbidities and a high socioeconomic burden. However, there is a general lack of awareness and knowledge about MASLD and its progressive stages (metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis). Therefore, MASLD is still far underdiagnosed. The \u2018Global Research Initiative for Patient Screening on MASH\u2019 (GRIPonMASH) consortium focuses on this unmet public health need. GRIPonMASH will help (primary) healthcare providers to implement a patient care pathway, as recommended by multiple scientific societies, to identify patients at risk of severe MASLD and to raise awareness. Furthermore, GRIPonMASH will contribute to a better understanding of the pathophysiology of MASLD and improved identification of diagnostic and prognostic markers to detect individuals at risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a prospective multicentre observational study in which 10 000 high-risk patients (type 2 diabetes mellitus, obesity, metabolic syndrome or hypertension) will be screened in 10 European countries using at least two non-invasive tests (Fibrosis-4 index and FibroScan). Blood samples and liver biopsy material will be collected and biobanked, and multiomics analyses will be conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The study will be conducted in compliance with this protocol and applicable national and international regulatory requirements. The study initiation package is submitted at the local level. The study protocol has been approved by local medical ethical committees in all 10 participating countries. Results will be made public and published in scientific, peer-reviewed, international journals and at international conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Registration details<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05651724\">NCT05651724<\/jats:ext-link>\n                      , registration date: 15 Dec 2022.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-092731","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T06:40:31Z","timestamp":1748587231000},"page":"e092731","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Global research initiative for patient screening on MASH (GRIPonMASH) protocol: rationale and design of a prospective multicentre study"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct05651724","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4692-479X","authenticated-orcid":false,"given":"Vivian D","family":"de Jong","sequence":"first","affiliation":[{"name":"Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands"},{"name":"Julius Clinical BV, Zeist, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Alings","sequence":"additional","affiliation":[{"name":"Cardiology, Amphia Hospital, Breda, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radan","family":"Bruha","sequence":"additional","affiliation":[{"name":"General University Hospital and the First Faculty of Medicine, Charles University, Praha, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Cortez-Pinto","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Universit\u00e1ria de Gastrenterologia, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George V","family":"Dedoussis","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Dietetics, Harokopio University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail","family":"Doukas","sequence":"additional","affiliation":[{"name":"Pathology, Erasmus MC Universitair Medisch Centrum Rotterdam, Rotterdam, Zuid-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Francque","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University Hospital Antwerp, Edegem, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Fournier-Poizat","sequence":"additional","affiliation":[{"name":"Echosens SA, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Gastaldelli","sequence":"additional","affiliation":[{"name":"Institute of Clinical Physiology, National Research Council, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hankemeier","sequence":"additional","affiliation":[{"name":"Leiden Academic Centre for Drug Research, Leiden University, Leiden, Zuid-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan G","family":"Holleboom","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine and Internal Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Miele","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Universit\u00e0 Cattolica del Sacro Cuore - Campus di Roma, Roma, Lazio, Italy"},{"name":"Liver Transplant Unit and Steatotic Liver Disease Clinic, Digestive Disease Center CEMAD, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Lazio, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Moreno","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, Hopital Erasme, Bruxelles, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8780-476X","authenticated-orcid":false,"given":"Jean W M","family":"Muris","sequence":"additional","affiliation":[{"name":"Family Medicine, Maastricht University, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlad","family":"Ratziu","sequence":"additional","affiliation":[{"name":"ICAN \u2013 Institute for Cardiometabolism and Nutrition, H\u00f4pital Piti\u00e9 Salp\u00eatri\u00e8re, Sorbonne University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8494-8947","authenticated-orcid":false,"given":"Manuel","family":"Romero-Gomez","sequence":"additional","affiliation":[{"name":"UCM Digestive Diseases and SeLiver Group, Virgen del Rocio University Hospital, Institute of Biomedicine of Seville (HUVR\/CSIC\/US), University of Seville, Sevilla, Andaluc\u00eda, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rn M","family":"Schattenberg","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Saarland University Hospital, Homburg, Saarland, Germany"},{"name":"Saarland University, Saarbrucken, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Serfaty","sequence":"additional","affiliation":[{"name":"H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D Cristina","family":"Stefan","sequence":"additional","affiliation":[{"name":"Meric Global, Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten E","family":"Tushuizen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Verheij","sequence":"additional","affiliation":[{"name":"Pathology, Amsterdam UMC, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Willemse","sequence":"additional","affiliation":[{"name":"Liver Patients International, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar H","family":"Franco","sequence":"additional","affiliation":[{"name":"Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederick E","family":"Grobbee","sequence":"additional","affiliation":[{"name":"Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands"},{"name":"Julius Clinical BV, Zeist, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Castro Cabezas","sequence":"additional","affiliation":[{"name":"Julius Clinical BV, Zeist, The Netherlands"},{"name":"Department of Internal Medicine, Franciscus Gasthuis en Vlietland, Rotterdam, Zuid-Holland, The Netherlands"},{"name":"Endocrinology, Erasmus University Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"2025121404362996000_15.5.e092731.1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000520"},{"key":"2025121404362996000_15.5.e092731.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.12.012"},{"key":"2025121404362996000_15.5.e092731.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.05.013"},{"key":"2025121404362996000_15.5.e092731.4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27368"},{"key":"2025121404362996000_15.5.e092731.5","doi-asserted-by":"crossref","unstructured":"Driessen S , Francque SM , Anker SD , et al . Metabolic dysfunction-associated steatotic liver disease and the heart. Hepatology 2023. doi:10.1097\/HEP.0000000000000735","DOI":"10.1097\/HEP.0000000000000735"},{"key":"2025121404362996000_15.5.e092731.6","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000004"},{"key":"2025121404362996000_15.5.e092731.7","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00317-X"},{"key":"2025121404362996000_15.5.e092731.8","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17158"},{"key":"2025121404362996000_15.5.e092731.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.06.021"},{"key":"2025121404362996000_15.5.e092731.10","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/liv.14825","article-title":"Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis","volume":"41","author":"Schattenberg","year":"2021","journal-title":"Liver Int"},{"key":"2025121404362996000_15.5.e092731.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01701-3"},{"key":"2025121404362996000_15.5.e092731.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32511-3"},{"key":"2025121404362996000_15.5.e092731.13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431"},{"key":"2025121404362996000_15.5.e092731.14","doi-asserted-by":"crossref","first-page":"100089","DOI":"10.1016\/j.endmts.2021.100089","article-title":"The global epidemiology of nonalcoholic steatohepatitis (NASH) and associated risk factors\u2013a targeted literature review","volume":"3","author":"Dufour","year":"2021","journal-title":"Endocr Metab Sci"},{"key":"2025121404362996000_15.5.e092731.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2029349"},{"key":"2025121404362996000_15.5.e092731.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"2025121404362996000_15.5.e092731.17","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S2468-1253(23)00141-3","article-title":"Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis","volume":"8","author":"M\u00f3zes","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025121404362996000_15.5.e092731.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0088-6"},{"key":"2025121404362996000_15.5.e092731.19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/liv.13311","article-title":"Non-pharmacological interventions in non-alcoholic fatty liver disease patients","volume":"37 Suppl 1","author":"Ratziu","year":"2017","journal-title":"Liver Int"},{"key":"2025121404362996000_15.5.e092731.20","doi-asserted-by":"crossref","first-page":"986","DOI":"10.14218\/JCTH.2021.00448","article-title":"Endoscopic Bariatric and Metabolic Therapies for Liver Disease: Mechanisms, Benefits, and Associated Risks","volume":"10","author":"Ren","year":"2022","journal-title":"J Clin Transl Hepatol"},{"key":"2025121404362996000_15.5.e092731.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2309000"},{"key":"2025121404362996000_15.5.e092731.22","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","article-title":"Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease","volume":"161","author":"Kanwal","year":"2021","journal-title":"Gastroenterology"},{"key":"2025121404362996000_15.5.e092731.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.025"},{"key":"2025121404362996000_15.5.e092731.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.03.033"},{"key":"2025121404362996000_15.5.e092731.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.04.031"},{"key":"2025121404362996000_15.5.e092731.26","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000323"},{"key":"2025121404362996000_15.5.e092731.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2022.03.010"},{"key":"2025121404362996000_15.5.e092731.28","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000116"},{"key":"2025121404362996000_15.5.e092731.29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2021.100411","article-title":"Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions","volume":"4","author":"Anstee","year":"2022","journal-title":"JHEP Rep"},{"key":"2025121404362996000_15.5.e092731.30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2021.100234","article-title":"European \u201cNAFLD Preparedness Index\u201d - Is Europe ready to meet the challenge of fatty liver disease?","volume":"3","author":"Lazarus","year":"2021","journal-title":"JHEP Rep"},{"key":"2025121404362996000_15.5.e092731.31","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2021.1974295"},{"key":"2025121404362996000_15.5.e092731.32","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/ueg2.12445","article-title":"A global survey of health care workers\u2019 awareness of non-alcoholic fatty liver disease: The AwareNASH survey","volume":"11","author":"Driessen","year":"2023","journal-title":"United European Gastroenterol J"},{"key":"2025121404362996000_15.5.e092731.33","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S2468-1253(23)00017-1","article-title":"Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study","volume":"8","author":"Vali","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025121404362996000_15.5.e092731.34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2022.100596","article-title":"Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice","volume":"5","author":"Lazarus","year":"2023","journal-title":"JHEP Rep"},{"key":"2025121404362996000_15.5.e092731.35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277706","article-title":"Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-\u03b1\/\u03b3 agonist aleglitazar","volume":"17","author":"Grobbee","year":"2022","journal-title":"PLoS One"},{"key":"2025121404362996000_15.5.e092731.36","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025121404362996000_15.5.e092731.37","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2298"},{"key":"2025121404362996000_15.5.e092731.38","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jhep.2019.12.008","article-title":"Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease","volume":"72","author":"Nascimbeni","year":"2020","journal-title":"J Hepatol"},{"key":"2025121404362996000_15.5.e092731.39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043134","article-title":"A 14-item Mediterranean diet assessment tool and obesity indexes among high-risk subjects: the PREDIMED trial","volume":"7","author":"Mart\u00ednez-Gonz\u00e1lez","year":"2012","journal-title":"PLoS One"},{"key":"2025121404362996000_15.5.e092731.40","doi-asserted-by":"publisher","DOI":"10.1249\/01.MSS.0000078924.61453.FB"},{"key":"2025121404362996000_15.5.e092731.41","doi-asserted-by":"publisher","DOI":"10.1037\/pas0000959"},{"key":"2025121404362996000_15.5.e092731.42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2021.100322","article-title":"Non-alcoholic fatty liver disease: A patient guideline","volume":"3","author":"Francque","year":"2021","journal-title":"JHEP Rep"},{"key":"2025121404362996000_15.5.e092731.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.04.003"},{"key":"2025121404362996000_15.5.e092731.44","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.cgh.2021.12.034","article-title":"Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population","volume":"20","author":"Graupera","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025121404362996000_15.5.e092731.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.04.013"},{"key":"2025121404362996000_15.5.e092731.46","doi-asserted-by":"crossref","DOI":"10.3390\/nu11122971","article-title":"Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered","volume":"11","author":"Plaz Torres","year":"2019","journal-title":"Nutrients"},{"key":"2025121404362996000_15.5.e092731.47","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.01.042"},{"key":"2025121404362996000_15.5.e092731.48","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317334"},{"key":"2025121404362996000_15.5.e092731.49","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13481","article-title":"Evaluation of nonalcoholic fatty liver disease (NAFLD) in severe obesity using noninvasive tests and imaging techniques","volume":"23","author":"Theel","year":"2022","journal-title":"Obes Rev"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-092731","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T12:36:39Z","timestamp":1765715799000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-092731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,30]]},"published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1136\/bmjopen-2024-092731"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-092731","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]}}}